Probiotics and Herbals as a Boom in Treatment of Ulcerative Colitis

被引:0
作者
Singh, Amandeep [1 ,2 ]
Singh, Gurmeet [1 ]
Bhattacharya, Sankha [1 ]
Mishra, Neeraj [3 ]
Thakur, Amisha [4 ]
Mandal, Uttam Kumar [2 ]
Narang, Raj Kumar [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut, Moga 142001, Punjab, India
[2] Maharaja Ranjit Singh Punjab Tech Univ, Dept Pharmaceut Sci & Technol, Bathinda, Punjab, India
[3] Amity Inst Pharm, Dept Pharmaceut, Gwalior, Madhya Pradesh, India
[4] ISF Coll Pharm, Dept Qual Assurance, Moga, Punjab, India
关键词
5-amino salicylic acid; Crohn's disease; cytokines; Mycobacterium avium; probiotics; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; EXTRAINTESTINAL MANIFESTATIONS; NATURAL-HISTORY; GUT MICROBIOTA; REMISSION; EFFICACY; THERAPY; CROHNS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. In its most limited form, it may be restricted to the distal rectum, while in its most extended form, the entire colon is involved. UC is identified by mucus diarrhea, tenesmus, bowel distension, and anemia. 5-aminosalicylic acid drugs, steroids, and immunosuppressant are used for therapy of UC. The annual occurrence of disease in Asia, America, and Europe was estimated to be 6.3, 19.2, and 24.3/100,000 people years. The main challenges in the management of the disease are drug-related side effects and local targeting. To overcome these challenges, probiotics overcome drug-related adverse side effects and local targeting. On ingestion, the probiotics can result in health beneficial effects. Probiotics are mainly used as gut modulators but are also nowadays explored for their use in UC.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 38 条
[1]  
AbduAllah HH., 2016, Medicinal Chemistry, V6, P306, DOI [10.4172/2161-0444.1000317, DOI 10.4172/2161-0444.1000361]
[2]   Osteoporosis in Inflammatory Bowel Disease [J].
Ali, Tauseef ;
Lam, David ;
Bronze, Michael S. ;
Humphrey, Mary Beth .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (07) :599-604
[3]   Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties [J].
Biagioli, Michele ;
Capobianco, Daniela ;
Carino, Adriana ;
Marchiano, Silvia ;
Fiorucci, Chiara ;
Ricci, Patrizia ;
Distrutti, Eleonora ;
Fiorucci, Stefano .
NUTRIENTS, 2019, 11 (02)
[4]   VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[5]  
Chang L, 2001, AM J GASTROENTEROL, V96, P3341
[6]   Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: Current perspectives [J].
Cipolla, G ;
Crema, F ;
Sacco, S ;
Moro, E ;
De Ponti, F ;
Frigo, G .
PHARMACOLOGICAL RESEARCH, 2002, 46 (01) :1-6
[7]   Extraintestinal manifestations in inflammatory bowel disease [J].
Danese, Silvio ;
Semeraro, Stefano ;
Papa, Alfredo ;
Roberto, Italia ;
Scaldaferri, Franco ;
Fedeli, Giuseppe ;
Gasbarrini, Giovanni ;
Gasbarrini, Antonio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (46) :7227-7236
[8]   Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR [J].
Delroisse, Jean-Marc ;
Boulvin, Anne-Lise ;
Parmentier, Isabelle ;
Dauphin, Robin Dubois ;
Vandenbol, Micheline ;
Portetelle, Daniel .
MICROBIOLOGICAL RESEARCH, 2008, 163 (06) :663-670
[9]   Probiotics and prebiotics in ulcerative colitis [J].
Derikx, Lauranne A. A. P. ;
Dieleman, Levinus A. ;
Hoentjen, Frank .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (01) :55-71
[10]   Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease [J].
Marjolijn Duijvestein ;
Robert Battat ;
Niels Vande Casteele ;
Geert R. D’Haens ;
William J. Sandborn ;
Reena Khanna ;
Vipul Jairath ;
Brian G. Feagan .
Current Treatment Options in Gastroenterology, 2018, 16 (1) :129-146